AAV1.NT-3 gene therapy prevents age-related sarcopenia
Burçak Özeş(Nationwide Children's Hospital), Zarife Sahenk(The Ohio State University)
Cited by 16
Related Papers
Eteplirsen for the treatment of Duchenne muscular dystrophy
|Annals of Neurology|2013|793
Dystrophin Immunity in Duchenne's Muscular Dystrophy
|New England Journal of Medicine|2010|655
Myoblast Transfer in the Treatment of Duchenne's Muscular Dystrophy
|New England Journal of Medicine|1995|522
Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy
|JAMA Neurology|2020|387
Gentamicin‐induced readthrough of stop codons in duchenne muscular dystrophy
|Annals of Neurology|2010|272